세계의 여행자 설사 치료 시장 보고서(2025년)

Traveler´s Diarrhea Treatment Global Market Report 2025

US $ 4,490 ￦ 6,203,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,967,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,730,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

여행자 설사 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 예측 기간 동안 예상되는 성장은 식중독 사례의 증가, 셀리악병 진단 건수의 증가, 설사 방지제에 대한 수요 증가, 모험과 생태 관광의 인기 증가, 그리고 해외 여행 증가에 기인한다고 생각됩니다. 이 기간의 주요 동향으로는 신규 치료법의 개발, 프로바이오틱스나 마이크로바이옴 기반의 치료법의 사용, 신속 진단 툴의 진보, 예방 백신의 도입, 위장약의 지속적인 성장 등을 들 수 있습니다.

여행자 증가가 여행자 설사 치료 시장의 확대를 견인할 것으로 예측됩니다. 여행객 증가에 기여하는 요인으로는 가처분 소득 증가, 저가 항공사의 성장, 비자 요건 간소화, 체험 관광의 인기 상승 등이 있습니다. 여행자 설사 치료는 증상을 빠르게 완화하고 탈수를 방지하며 빠른 회복을 가능하게 하여 여행자가 최소한의 방해로 여행을 계속할 수 있도록 도와줍니다. 2023년 3월 미국 교통통계국은 미국 항공사들이 2022년에 8억 5,300만 명의 승객을 수송했으며, 이는 2021년의 6억 5,800만 명에서 1억 9,400만 명 증가한 수치라고 보고했습니다. 그 결과 여행의 급증이 여행자 설사 치료 시장의 성장을 견인하고 있습니다.

식중독 환자 수 증가는 여행자 설사 치료 시장의 성장을 가속할 것으로 예측됩니다. 중독 환자 증가는 부적절한 식품 취급, 살모넬라 및 대장균과 같은 박테리아 오염, 불충분한 냉장, 가공 식품 및 조리 식품의 소비량 증가와 같은 요인과 관련이 있습니다. 치료는 수분 보급 요법, 항균제, 프로바이오틱스를 통해 탈수, 메스꺼움, 복부 경련 등의 식중독 증상을 관리하고 조기 회복과 합병증의 경감을 촉진합니다. EU는 2022년에 5,763건의 식중독이 발생했으며, 2021년에 비해 44% 증가했다고 보고했습니다. 그 결과, 식중독의 발생률 증가가 여행자 설사 치료 시장의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 여행자 설사 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 여행자 설사 치료 시장 : 성장률 분석
• 세계의 여행자 설사 치료 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 여행자 설사 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 여행자 설사 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 여행자 설사 치료 시장 : 약제 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 항생제
• 설사 방지
• 기타 약제 유형
• 세계의 여행자 설사 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경구
• 비경구
• 세계의 여행자 설사 치료 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 성인 여행자 설사
• 소아 여행자 설사증
• 세계의 여행자 설사 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원
• 재택치료
• 전문 클리닉
• 기타
• 세계의 여행자 설사 치료 시장 : 항생 물질별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 플루오로퀴놀론
• 마크로라이드
• 리파마이신
• 세계의 여행자 설사 치료 시장 : 설사 억제 약제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 로페라미드
• 다음 살리실산 비스무트
• 세계의 여행자 설사 치료 시장 : 기타 약제 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 경구 보수 요법
• 프로바이오틱스
• 아연 보충제

제7장 지역별/국가별 분석

• 세계의 여행자 설사 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 여행자 설사 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 여행자 설사 치료 시장 : 경쟁 구도
• 여행자 설사 치료 시장 : 기업 프로파일
  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Sanofi SA
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.

제31장 기타 주요 기업 및 혁신 기업

• CH Boehringer Sohn AG & Co. KG
• Astellas Pharma Inc.
• Aurobindo Pharma Limited
• Lupin Pharmaceuticals Inc.
• Mallinckrodt plc
• Glenmark Pharmaceuticals Ltd.
• Indivior plc
• Immuron Limited
• Valneva SE
• Cosmo Pharmaceuticals NV
• Otsuka Pharmaceutical Co. Ltd.
• Lumen Bioscience Inc.
• RedHill Biopharma Ltd.
• Brown & Burk Pharmaceuticals Ltd.
• Scandinavian Biopharma Holding AB

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 여행자 설사 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
• 여행자 설사 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
• 여행자 설사 치료 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Traveler's diarrhea is a common illness that occurs when individuals consume contaminated food or water while traveling. It is typically marked by frequent, loose stools, abdominal cramps, and sometimes nausea or vomiting. Treatment focuses on rehydration with oral rehydration solutions, the use of anti-diarrheal medications such as loperamide, and antibiotics in more severe cases.

The primary types of drugs used to treat traveler's diarrhea include antibiotics, anti-diarrheal medications, and other drug types. Antibiotics work by treating bacterial infections, either killing bacteria or inhibiting their growth. These drugs are administered through various routes, including oral and parenteral, and are used in treating both adult and children's traveler's diarrhea. The main end users of these medications include hospitals, homecare settings, specialty clinics, and other healthcare providers.

The traveler's diarrhea treatment market research report is one of a series of new reports from The Business Research Company that provides traveler's diarrhea treatment market statistics, including the traveler's diarrhea treatment industry global market size, regional shares, competitors with the traveler's diarrhea treatment market share, detailed traveler's diarrhea treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the traveler's diarrhea treatment industry. This traveler's diarrhea treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The traveler's diarrhea treatment market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.60 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing cases of viral, bacterial, and parasitic infections, a rise in chronic diseases, greater awareness of travel-related illnesses, a higher prevalence of traveler's diarrhea, and an increase in food poisoning incidents.

The traveler's diarrhea treatment market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The projected growth in the forecast period can be attributed to the rising prevalence of food poisoning cases, an increasing number of celiac disease diagnoses, a higher demand for anti-diarrheal medications, the growing popularity of adventure and eco-tourism, and a rise in international travel. Key trends during this period include the development of novel treatments, the use of probiotics and microbiome-based therapies, advancements in rapid diagnostic tools, the introduction of vaccines for prevention, and the continued growth of gastrointestinal drugs.

The growing number of travelers is expected to drive the expansion of the traveler's diarrhea treatment market. Travelers are individuals who move from one location to another, typically for leisure, business, or other reasons. Factors contributing to the rise in travelers include increasing disposable incomes, the growth of budget airlines, simplified visa requirements, and the rising popularity of experiential tourism. Traveler's diarrhea treatments assist by quickly alleviating symptoms, preventing dehydration, and enabling faster recovery, allowing travelers to continue their trips with minimal disruption. For example, in March 2023, the Bureau of Transportation Statistics reported that U.S. airlines transported 853 million passengers in 2022, an increase of 194 million from the 658 million carried in 2021. Consequently, the surge in travel is driving the growth of the traveler's diarrhea treatment market.

The increasing number of food poisoning cases is also expected to fuel the growth of the traveler's diarrhea treatment market. Food poisoning occurs from consuming contaminated food or beverages, often due to bacteria, viruses, parasites, or toxins. The rise in food poisoning cases is linked to factors such as improper food handling, contamination by bacteria such as Salmonella and E. coli, inadequate refrigeration, and a higher consumption of processed and ready-to-eat foods. Treatments for traveler's diarrhea help manage food poisoning symptoms such as dehydration, nausea, and abdominal cramps through rehydration therapy, antimicrobial medications, and probiotics, promoting quicker recovery and reducing complications. In December 2024, the European Food Safety Authority reported that the EU saw 5,763 foodborne outbreaks in 2022, reflecting a 44% increase compared to 2021. As a result, the growing incidence of food poisoning is contributing to the growth of the traveler's diarrhea treatment market.

Companies in the traveler's diarrhea treatment market are also focusing on developing innovative products such as delayed-release tablets to enhance treatment efficacy and reduce dosing frequency. These tablets are designed to release active ingredients at specific times after ingestion, ensuring the medication reaches the intestines before dissolving, which helps treat traveler's diarrhea effectively while minimizing stomach irritation. For example, in September 2023, Adalvo Ltd., based in Malta, partnered with Cosmo Pharmaceuticals N.V., based in Ireland, to launch Rifamycin SV MMX 200 mg (Aemcolo). This medication treats traveler's diarrhea by delivering a non-absorbed antibiotic directly to the colon, alleviating symptoms while minimizing disruption to beneficial gut bacteria. This targeted approach offers effective relief with a lower risk of systemic side effects and multi-drug resistance.

Major players in the traveler's diarrhea treatment market are Johnson & Johnson Services Inc., Bayer AG, Sanofi SA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, Astellas Pharma Inc., Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., Mallinckrodt plc, Glenmark Pharmaceuticals Ltd., Indivior plc, Immuron Limited, Valneva SE, Cosmo Pharmaceuticals N.V., Otsuka Pharmaceutical Co. Ltd., Lumen Bioscience Inc., RedHill Biopharma Ltd., Brown & Burk Pharmaceuticals Ltd., Scandinavian Biopharma Holding AB.

North America was the largest region in the traveler's diarrhea treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traveler's diarrhea treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the traveler's diarrhea treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The traveler's diarrhea treatment market consists of revenues earned by entities by providing services such as probiotics and preventive supplements, telemedicine and online consultations, travel vaccinations and preventive care, medical insurance and assistance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The traveler's diarrhea treatment market also includes sales of oral rehydration salts (ORS), antimotility agents, probiotics, and bismuth subsalicylate products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Traveler's Diarrhea Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on traveler's diarrhea treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for traveler's diarrhea treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The traveler's diarrhea treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Antibiotics; Anti-diarrheal; Other Drug Types
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Application: Adult Traveler's Diarrhea; Children Traveler's Diarrhea
• 4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Antibiotics: Fluoroquinolones; Macrolides; Rifamycins
• 2) By Anti-diarrheal: Loperamide; Bismuth Subsalicylate
• 3) By Other Drug Types: Oral Rehydration Therapy; Probiotics; Zinc Supplements
• Companies Mentioned: Johnson & Johnson Services Inc.; Bayer AG; Sanofi SA; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Traveler's Diarrhea Treatment Market Characteristics

3. Traveler's Diarrhea Treatment Market Trends And Strategies

4. Traveler's Diarrhea Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Traveler's Diarrhea Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Traveler's Diarrhea Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Traveler's Diarrhea Treatment Market Growth Rate Analysis
• 5.4. Global Traveler's Diarrhea Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Traveler's Diarrhea Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Traveler's Diarrhea Treatment Total Addressable Market (TAM)

6. Traveler's Diarrhea Treatment Market Segmentation

• 6.1. Global Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Anti-diarrheal
• Other Drug Types
• 6.2. Global Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.3. Global Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Traveler's Diarrhea
• Children Traveler's Diarrhea
• 6.4. Global Traveler's Diarrhea Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluoroquinolones
• Macrolides
• Rifamycins
• 6.6. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Anti-diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Loperamide
• Bismuth Subsalicylate
• 6.7. Global Traveler's Diarrhea Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Rehydration Therapy
• Probiotics
• Zinc Supplements

7. Traveler's Diarrhea Treatment Market Regional And Country Analysis

• 7.1. Global Traveler's Diarrhea Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Traveler's Diarrhea Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Traveler's Diarrhea Treatment Market

• 8.1. Asia-Pacific Traveler's Diarrhea Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Traveler's Diarrhea Treatment Market

• 9.1. China Traveler's Diarrhea Treatment Market Overview
• 9.2. China Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Traveler's Diarrhea Treatment Market

• 10.1. India Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Traveler's Diarrhea Treatment Market

• 11.1. Japan Traveler's Diarrhea Treatment Market Overview
• 11.2. Japan Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Traveler's Diarrhea Treatment Market

• 12.1. Australia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Traveler's Diarrhea Treatment Market

• 13.1. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Traveler's Diarrhea Treatment Market

• 14.1. South Korea Traveler's Diarrhea Treatment Market Overview
• 14.2. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Traveler's Diarrhea Treatment Market

• 15.1. Western Europe Traveler's Diarrhea Treatment Market Overview
• 15.2. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Traveler's Diarrhea Treatment Market

• 16.1. UK Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Traveler's Diarrhea Treatment Market

• 17.1. Germany Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Traveler's Diarrhea Treatment Market

• 18.1. France Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Traveler's Diarrhea Treatment Market

• 19.1. Italy Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Traveler's Diarrhea Treatment Market

• 20.1. Spain Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Traveler's Diarrhea Treatment Market

• 21.1. Eastern Europe Traveler's Diarrhea Treatment Market Overview
• 21.2. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Traveler's Diarrhea Treatment Market

• 22.1. Russia Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Traveler's Diarrhea Treatment Market

• 23.1. North America Traveler's Diarrhea Treatment Market Overview
• 23.2. North America Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Traveler's Diarrhea Treatment Market

• 24.1. USA Traveler's Diarrhea Treatment Market Overview
• 24.2. USA Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Traveler's Diarrhea Treatment Market

• 25.1. Canada Traveler's Diarrhea Treatment Market Overview
• 25.2. Canada Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Traveler's Diarrhea Treatment Market

• 26.1. South America Traveler's Diarrhea Treatment Market Overview
• 26.2. South America Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Traveler's Diarrhea Treatment Market

• 27.1. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Traveler's Diarrhea Treatment Market

• 28.1. Middle East Traveler's Diarrhea Treatment Market Overview
• 28.2. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Traveler's Diarrhea Treatment Market

• 29.1. Africa Traveler's Diarrhea Treatment Market Overview
• 29.2. Africa Traveler's Diarrhea Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Traveler's Diarrhea Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Traveler's Diarrhea Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Traveler's Diarrhea Treatment Market Competitive Landscape And Company Profiles

• 30.1. Traveler's Diarrhea Treatment Market Competitive Landscape
• 30.2. Traveler's Diarrhea Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Traveler's Diarrhea Treatment Market Other Major And Innovative Companies

• 31.1. C.H. Boehringer Sohn AG & Co. KG
• 31.2. Astellas Pharma Inc.
• 31.3. Aurobindo Pharma Limited
• 31.4. Lupin Pharmaceuticals Inc.
• 31.5. Mallinckrodt plc
• 31.6. Glenmark Pharmaceuticals Ltd.
• 31.7. Indivior plc
• 31.8. Immuron Limited
• 31.9. Valneva SE
• 31.10. Cosmo Pharmaceuticals N.V.
• 31.11. Otsuka Pharmaceutical Co. Ltd.
• 31.12. Lumen Bioscience Inc.
• 31.13. RedHill Biopharma Ltd.
• 31.14. Brown & Burk Pharmaceuticals Ltd.
• 31.15. Scandinavian Biopharma Holding AB

32. Global Traveler's Diarrhea Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Traveler's Diarrhea Treatment Market

34. Recent Developments In The Traveler's Diarrhea Treatment Market

35. Traveler's Diarrhea Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Traveler's Diarrhea Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Traveler's Diarrhea Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Traveler's Diarrhea Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료